In this issue

Jonathan Tobin: Defending the Right to a Jewish State

Heather Hale: Compliment your kids without giving them big heads

Megan Shauri: 10 ways you are ruining your own happiness

Carolyn Bigda: 8 Best Dividend Stocks for 2015

Kiplinger's Personal Finance editors: 7 Things You Didn't Know About Paying Off Student Loans

Samantha Olson: The Crucial Mistake 55% Of Parents Are Making At Their Baby's Bedtime

Densie Well, Ph.D., R.D. Open your eyes to yellow vegetables

The Kosher Gourmet by Megan Gordon With its colorful cache of purples and oranges and reds, COLLARD GREEN SLAW is a marvelous mood booster --- not to mention just downright delish
April 18, 2014

Rabbi Yonason Goldson: Clarifying one of the greatest philosophical conundrums in theology

Caroline B. Glick: The disappearance of US will

Megan Wallgren: 10 things I've learned from my teenagers

Lizette Borreli: Green Tea Boosts Brain Power, May Help Treat Dementia

John Ericson: Trying hard to be 'positive' but never succeeding? Blame Your Brain

The Kosher Gourmet by Julie Rothman Almondy, flourless torta del re (Italian king's cake), has royal roots, is simple to make, . . . but devour it because it's simply delicious

April 14, 2014

Rabbi Dr Naftali Brawer: Passover frees us from the tyranny of time

Greg Crosby: Passing Over Religion

Eric Schulzke: First degree: How America really recovered from a murder epidemic

Georgia Lee: When love is not enough: Teaching your kids about the realities of adult relationships

Cameron Huddleston: Freebies for Your Lawn and Garden

Gordon Pape: How you can tell if your financial adviser is setting you up for potential ruin

Dana Dovey: Up to 500,000 people die each year from hepatitis C-related liver disease. New Treatment Has Over 90% Success Rate

Justin Caba: Eating Watermelon Can Help Control High Blood Pressure

The Kosher Gourmet by Joshua E. London and Lou Marmon Don't dare pass over these Pesach picks for Manischewitz!

April 11, 2014

Rabbi Hillel Goldberg: Silence is much more than golden

Caroline B. Glick: Forgetting freedom at Passover

Susan Swann: How to value a child for who he is, not just what he does

Cameron Huddleston: 7 Financial Tasks You Should Tackle Right Now

Sandra Block and Lisa Gerstner: How to Profit From Your Passion

Susan Scutti: A Simple Blood Test Might Soon Diagnose Cancer

Chris Weller: Have A Slow Metabolism? Let Science Speed It Up For You

The Kosher Gourmet by Diane Rossen Worthington Whitefish Terrine: A French take on gefilte fish

April 9, 2014

Jonathan Tobin: Why Did Kerry Lie About Israeli Blame?

Samuel G. Freedman: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Jessica Ivins: A resolution 70 years later for a father's unsettling legacy of ashes from Dachau

Kim Giles: Asking for help is not weakness

Kathy Kristof and Barbara Hoch Marcus: 7 Great Growth Israeli Stocks

Matthew Mientka: How Beans, Peas, And Chickpeas Cleanse Bad Cholesterol and Lowers Risk of Heart Disease

Sabrina Bachai: 5 At-Home Treatments For Headaches

The Kosher Gourmet by Daniel Neman Have yourself a matzo ball: The secrets bubby never told you and recipes she could have never imagined

April 8, 2014

Lori Nawyn: At Your Wit's End and Back: Finding Peace

Susan B. Garland and Rachel L. Sheedy: Strategies Married Couples Can Use to Boost Benefits

David Muhlbaum: Smart Tax Deductions Non-Itemizers Can Claim

Jill Weisenberger, M.S., R.D.N., C.D.E : Before You Lose Your Mental Edge

Dana Dovey: Coffee Drinkers Rejoice! Your Cup Of Joe Can Prevent Death From Liver Disease

Chris Weller: Electric 'Thinking Cap' Puts Your Brain Power Into High Gear

The Kosher Gourmet by Marlene Parrish A gift of hazelnuts keeps giving --- for a variety of nutty recipes: Entree, side, soup, dessert

April 4, 2014

Rabbi David Gutterman: The Word for Nothing Means Everything

Charles Krauthammer: Kerry's folly, Chapter 3

Amy Peterson: A life of love: How to build lasting relationships with your children

John Ericson: Older Women: Save Your Heart, Prevent Stroke Don't Drink Diet

John Ericson: Why 50 million Americans will still have spring allergies after taking meds

Cameron Huddleston: Best and Worst Buys of April 2014

Stacy Rapacon: Great Mutual Funds for Young Investors

Sarah Boesveld: Teacher keeps promise to mail thousands of former students letters written by their past selves

The Kosher Gourmet by Sharon Thompson Anyone can make a salad, you say. But can they make a great salad? (SECRETS, TESTED TECHNIQUES + 4 RECIPES, INCLUDING DRESSINGS)

April 2, 2014

Paul Greenberg: Death and joy in the spring

Dan Barry: Should South Carolina Jews be forced to maintain this chimney built by Germans serving the Nazis?

Mayra Bitsko: Save me! An alien took over my child's personality

Frank Clayton: Get happy: 20 scientifically proven happiness activities

Susan Scutti: It's Genetic! Obesity and the 'Carb Breakdown' Gene

Lecia Bushak: Why Hand Sanitizer May Actually Harm Your Health

Stacy Rapacon: Great Funds You Can Own for $500 or Less

Cameron Huddleston: 7 Ways to Save on Home Decor

The Kosher Gourmet by Steve Petusevsky Exploring ingredients as edible-stuffed containers (TWO RECIPES + TIPS & TECHINQUES)

Jewish World Review

Study: How to Significantly Reduce Mortality from Certain Cancers Simply

By Thomas H. Maugh II

Study released yesterday by British researchers documents unknown effects of taking regular dosages of commonly found chewable tablets

http://www.JewishWorldReview.com | (MCT) A daily dose of baby aspirin may reduce mortality from a range of common cancers by an average of 21 percent, and the reduction persisted for at least 20 years, British researchers reported Monday.

Deadly cases of stomach, colorectal and esophageal cancers all declined among people who took low-dose aspirin for 10 to 20 years, according to a study published online in the journal Lancet. The chewable tablets also were linked to a reduced risk of death from adenocarcinoma and from lung cancer in nonsmokers.

The results were based on an analysis of more than 10,000 people who participated in seven clinical trials designed to test whether baby aspirin could reduce the risk of heart disease.

"We already had strong evidence that low-dose aspirin could reduce deaths from colorectal cancer by as much as a third, but this provides important new evidence that long-term aspirin use can provide protection against a variety of other cancers," said epidemiologist Eric Jacobs of the American Cancer Society. However, he added, "it would be premature at this point to recommend that people start using aspirin specifically to prevent cancer."

For the millions of people who are currently taking low doses of aspirin to protect against cardiovascular disease, "the findings suggest that they should have some additional benefit for cancer," said Dr. Lori Minasian, who is in charge of large cancer prevention trials at the National Cancer Institute.

Most of the studies examined by the British researchers involved primarily men, but the team said that the fundamental mechanisms involved probably hold equally for women. However, they added, there were not enough women involved in the studies to determine if daily aspirin could affect mortality from breast, ovarian or endometrial cancer.

A variety of studies in animals — and even in plants — show that salicylate, the active ingredient in aspirin, can suppress tumors. Observational data in the 1970s suggested that aspirin could suppress tumors in humans, but alternative explanations were offered and experts demanded randomized clinical trials.

In October, Dr. Peter M. Rothwell of the University of Oxford and his colleagues reported on an analysis of four clinical trials comparing a daily dose of 75 milligrams of aspirin to a placebo in the prevention of strokes. They found that those who received the aspirin reduced their risk of developing colon cancer by 24 percent and their risk of dying from the disease by 35 percent.


Every weekday NewsAndOpinion.com publishes what many in the media and Washington consider "must-reading". HUNDREDS of columnists and cartoonists regularly appear. Sign up for the daily update. It's free. Just click here.

(A dose of European baby aspirin is typically 75 mg; in the United States it is 81 mg. A typical full-strength aspirin tablet is 300 mg.)

In the new study, Rothwell and colleagues started with eight clinical trials involving 25,570 people. They found that during the period of the clinical trials, which typically lasted for about four years, the risk of death from cancer declined by about 21 percent among those who were in the aspirin group.

Digging further, the researchers realized that nearly half of the subjects had been tracked for two decades — long after their trials had ended. The researchers "spent several years looking through dusty archives" to track their fates and quantify the long-term benefits of aspirin for cancer prevention, Rothwell said in a news conference.

Over a 10-year period, baby aspirin was linked to a 32 percent reduction in the risk of lung cancers in nonsmokers and a 30 percent drop in the risk of death from adenocarcinoma, the study found. Longer term, aspirin was associated with a 64 percent decrease in fatal cases of esophageal cancer, a 58 percent drop in fatal cases of stomach cancer and a 49 percent reduction in the risk of death from colorectal cancer, the study found.

Aspirin was not found to influence the risk of death from pancreatic, prostate, bladder, kidney, brain or blood cancers, according to the Lancet report. Larger doses of aspirin, smoking and gender had no effect on the results.

Rothwell noted that most of the subjects stopped taking aspirin at the end of the study — or, alternatively, many in the control group began taking it — potentially confusing the results.

"It's likely that if people had carried on taking aspirin," the benefit would have been greater, he said. "The benefit increased quite steeply with the length of time people were on it."

Researchers are not quite sure how the aspirin works. In the test tube, when cells divide, there is a chance the DNA in the daughter cells will be faulty. Healthy cells will recognize those defects and either repair them or cause the defective cells to self-destruct, said Dr. Tom W. Meade of the University of London, a co-author of the paper.

"Both mechanisms are enhanced by aspirin," he said.

The biggest potential risk of aspirin is gastrointestinal bleeding. Rothwell noted that the normal risk of GI bleeding is about one in every 2,000 to 3,000 people per year, and aspirin increases that by about 60 percent. "So the increased risk of bleeding is about 1 in 1,000 per year, while the decreased risk of cancer is 2, 3 or 4 per 1,000 per year," he said.

Interested in a private Judaic studies instructor — for free? Let us know by clicking here.

Every weekday JewishWorldReview.com publishes inspirational material. Sign up for the daily JWR update. It's free. Just click here.

We want your comments! Please let us know what you think by clicking here.

© 2010, Los Angeles Times Distributed by McClatchy-Tribune Information Services.